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Abstract
Objectives The storage, use and disposal of controlled drugs (CDs) in hospitals and other health-
care centres are governed by a combination of government legislation and local policy. In the UK, 
a running balance must be kept for Schedule 2 CDs and when discrepancies arise, they must be in-
vestigated and reconciled. Policies on acceptable discrepancies are varied and based on anecdotal 
evidence. This study was designed to simulate dosing and stock check procedures for oxycodone 
oral solution, as a sample CD solution, and evaluate where the volume losses that cause discrep-
ancies could arise from.
Methods Hypromellose solutions were formulated to simulate oxycodone commercial solutions. 
These were used to simulate dosing and stock check practices. Quantification of volume loss 
during simulated routine dosing and stock check of viscous oral CD formulations were performed 
in triplicate.
Key findings Dosing with enteral syringes via a fitted rubber bung never resulted in volume loss. 
Volume loss was always observed during stock checks with no statistical difference between 
methods used.
Conclusions The findings of this study support the following recommendations. Hospital phar-
macy departments should provide oxycodone and other CD liquid formulation bottles pre-fitted 
with a bung and make sure personnel use enteral syringes that are compatible with the chosen 
adaptor and of the most appropriate size for the intended dose. Stock checks should be limited to 
the minimum required by law or local policy.
Keywords: controlled drugs; discrepancy; oxycodone; oral administration; enteral syringes
Introduction
In the UK, drugs defined as controlled drugs (CDs) are listed in the 
Misuse of Drugs Act 1971. The Misuse of Drugs Regulations 2001 
further classifies CDs into five different schedules depending on the 
level of control attributed to each. Schedule 2 contains the drugs 
for therapeutic use with the most stringent requirements in terms of 
prescription, supply, storage and destruction.[1] Similar classifications 
are used in different countries with strict laws governing the manu-
facture, supply and possession of these drugs.[2] Hospitals and other 
healthcare settings must comply with a combination of legal require-
ments and local policy for the storage, prescribing, administration 
and destruction of these substances. In secondary care settings, these 
include keeping a running balance of stock for each clinical and 
non-clinical area. However, maintaining an accurate record of the 
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occur through repeat dose preparation and periodic stock checks 
that involve multiple individuals. This is further complicated due to 
variable, but allowable, overage of CD volumes during manufac-
ture (confirmed by conversation with manufacturer). Anecdotally, 
healthcare organisations accept a 5% loss of the total volume, but 
this limit is arbitrarily determined.[1] Overall, there is uncertainty in 
clinical practice as to what constitutes loss through normal use and 
what loss may be due to the CD being misappropriated.[3–5] A 2013 
Australian study[6] determined a 4% discrepancy to be acceptable 
in the case of four different CD liquids [morphine hydrochloride 
(Ordine), oxycodone (OxyNorm), hydromorphone (Dilaudid) and 
methadone]. The experiments found that the least natural wastage 
was achieved by dosing the liquid medicines via a bottle-fitted bung 
using an enteral syringe.[6] The major limitation of this study was 
that the volume of dose measured was limited to 2.5 ml throughout 
the experiment, which does not reflect clinical practice where a range 
of doses are administered on a ward. A  2016 American study[7] 
aimed at defining the characteristics of controlled medication dis-
crepancies. The study identified 2468 discrepancies. The medicine 
found to have the highest discrepancy (15%) was the hydrocodone/
paracetamol combination. However, this study included a variety of 
dosage forms such as tablets, liquids, solutions for injection and con-
sidered both I/V and oral administration so it was not specific to oral 
liquid formulation. Furthermore, being a specialist trauma hospital, 
the results are likely to be skewed, due to the limited cross-section of 
patients seen at this facility, and may not be generalisable.[7] Overall, 
both the Australian and American studies emphasise the need for 
more published evidence-based information on oral CD liquid loss 
in practice.[6, 7] This study aimed to determine best practice in dose 
measurement and stock checking techniques to minimise loss of 
liquid medication, by simulating a range of methods in a labora-
tory setting using a hypromellose solution of viscosity equivalent to 




BD syringes (1.25, 10 and 60 ml) were supplied by Medisave and 
precision syringes (5  ml) were purchased from Valley Northern. 
Blaubrand Pycnometers (25  ml) and Poulten Selfe Ostwald 
Viscometer D (range 20–100  mm2/s) were obtained from Fisher 
Scientific. Hydroxypropyl methylcellulose (hypromellose; Mw 
86,000  Da) and citric acid 99.6% were obtained from Acros 
Organics; sodium citrate dihydrate and Alfa Aesar indigo carmine 
(food blue colouring) were from Fisher Scientific.
Preparation and characterisation of hypromellose 
stock solutions
Hypromellose solutions were used to simulate oxycodone oral for-
mulations as conditions for the use, storage and disposal of CDs 
could not be abided by on our premises. Hypromellose is the sus-
pending agent used in oxycodone formulations furthermore the 
manufacturer stated solutions had a pH of 3, we therefore tested 
the effect of hypromellose concentration and pH on the viscosity of 
the solution to best simulate the commercial formula. Hypromellose 
solutions were prepared by dispersing the polymer in either water 
or citrate buffer at 80°C and adding water to final weight after 
cooling the solution to room temperature. The sodium citrate buffer 
was prepared by dissolving sodium citrate (2.714  g) and citric 
acid (17.437 g) in deionised water to a final volume of 1 L (pH 3). 
Solutions were stored at 4°C until further use and made fresh fort-
nightly. The density and viscosity of the hypromellose solutions pre-
pared were determined experimentally using a pycnometer and an 
Ostwald viscometer. All measurements were carried out in triplicate.
Simulations
A series of tests was designed to simulate the common practices seen 
in the UK ward environments when preparing and administering li-
quid doses and when undertaking stock checks (Figure 1). Through 
informal conversation with hospital nurses regarding the extraction 
of small doses (e.g. 1.25 or 2.5 ml), we identified a number of dosing 
practices that informed the different techniques as described below.
Simulated dosing: cup
It is common practice in some hospital wards to pour a small volume 
of oral solution into a cup (paper or plastic) to facilitate measuring 
via an enteral syringe, the remaining solution is then returned to 
the stock bottle. This test was carried out to determine the residual 
volume when using a measuring cup and to investigate the effect of 
time and volume on loss. Before testing, 1 ml of food blue colouring 
was added to a 250  ml batch of hypromellose solution. A  paper 
or plastic medicine cup was weighed and tared on a top pan bal-
ance. Five grams of accurately weighed hypromellose solution were 
poured into the cup and left there for either 2 or 10  min before 
discarding and measuring the residual weight (Figure 2a). Colouring 
was used for visual inspection.
Simulated dosing: syringe
The stock solution (254 ml to include an overage) was poured into 
a tared, 250 ml amber bottle that was subsequently sealed with a 
permanent bung. Doses were taken from the bottle as illustrated in 
Table 1. Throughout the experiments, the weights of the empty syr-
inge, the filled syringe, the stock bottle from which the dose was 
taken and the discarded solution were recorded (Figure 2b). To re-
duce measurement error bias, a second researcher carried out a set of 
dosage extractions. The second researcher was not informed of the 
purpose of the experiment and simply asked to extract the dose in 
whichever way they thought was acceptable. A control experiment 
was also carried out with water instead of the hypromellose solution.
Simulated stock checks
Simulated stock checks were carried out using a variety of techniques 
that are used at the University Hospital Southampton pharmacy de-
partment and wards using an identical stock bottle sealed with a 
bung. The methods used to take a balance check were: (1) removing 
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the bung and pouring the remaining stock into a 250 ml measuring 
cylinder, (2) withdrawing the remaining volume with 60 ml enteral 
syringes via the fitted bung, (3) removing the bung and pouring the 
remaining stock into a 60 ml enteral syringe fitted with a stopper, (4) 
removing the bung, pouring the remaining stock into a cup (paper 
or plastic) and measuring by drawing into 60 ml enteral syringes. All 
doses were measured by weight and converted into volume by using 
the experimental density value. Weights were recorded in three ways: 
(a) weight of the filled syringe (syringe), (b) weight difference in the 
stock bottle (from stock), (c) and weight difference in the discard 
beaker (administered). All tests were carried out in normal ambient 
conditions and in triplicate.
Statistical analysis
Analysis of variance test was carried out followed by Tukey 
multicomparison test. Unpaired two-tailed t-test was carried out 
when comparing two samples. Details of the specific statistical 
methods used to analyse the different sets of data are reported in 
each figure caption. Data were plotted and analysed using GraphPad 
Prism 8.
Results
Characterisation of the stock solution
In order to simulate the measuring of clinically used formulations 
of oxycodone containing hypromellose as the suspending agent, a 
number of hypromellose solutions of different concentrations were 
prepared and their viscosity was measured (Table 2). Performing vis-
cosity testing on hypromellose solutions in water narrowed down 
a suitable range of concentrations between 0.25 and 0.5% w/w for 
obtaining the desired viscosity of 15 mPa·s (corresponding to the 
oxycodone commercially available solution). The addition of so-
dium citrate buffer to the formulation increased the viscosity. The 
target viscosity of 15 mPa·s was obtained using a 0.4375% w/w 
hypromellose buffered solution.
Simulated dosing: cup
A similar loss (P > 0.05) was found independent of the type of cup 
used in this method (Figure 3a). No statistical difference was found 
in the loss occurred when pouring 5 or 10 g of solution (Figure 3b). 
An increased concentration and therefore viscosity of hypromellose 
solution correlated with an increase in residual volume (Figure 3c). 
The highest residual volume (0.76 ± 0.06 ml) was found with buf-
fered 0.5% w/w solution left for 10 min.
Simulated dosing: syringe
Before simulating the extraction of doses, the most precise meas-
uring method was evaluated. The highest precision was achieved by 
Figure 2 Diagrams describing the procedure of simulated dosing: (a) cup and (b) syringe.
Table 1 Experimental design for dosing with a syringe
Dose volume
1.25 ml 2.5 ml 5 ml 10 ml
Experiment name Total volume 
to be dosed
Number of doses (percentage of total volume)
Fixed dose 2.5 250.00 ml – 100 – –
Fixed dose 5 250.00 ml – – 50 –
Fixed dose 10 250.00 ml – – – 25
Mixed doses – low 247.50 ml 100 (50%) 25 (25%) 6 (12.5%) 3 (12.5%)
Mixed doses – high 258.75 ml 25 (12%) 13 (13%) 13 (25%) 13 (50%)
Table 2 Density and viscosity values for experimental hypromellose 
solutions of different concentrations prepared to simulate the 
commercial oxycodone formulation that has a viscosity of 15 
mPa·s and a pH = 3
Solvent Hypromellose 
(% w/w)
Density (g/cm3) Viscosity 
(mPa·s)
Water 0.2500 1.01 ± 0.00 4.33 ± 0.07
0.5000 1.03 ± 0.00 18.64 ± 1.17
0.7500 1.00 ± 0.00 46.49 ± 2.77
Citrate buffer pH 4 0.4375 1.02 ± 0.02 14.84 ± 0.92
0.4500 1.02 ± 0.02 15.97 ± 0.37
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Figure 3 (a) Percentage liquid loss when 5 g of hypromellose 0.4375% w/w 
solution was poured into a paper or plastic cup and left for 2 min (t-test, P 
> 0.05). (b) Percentage liquid loss when 5 or 10 g of hypromellose 0.5% w/w 
was poured into a paper cup and left for 2 or 10 min (t-test: 5 versus 10 g 
and 2 versus 10 min, P > 0.05). (c) Percentage volume loss when 5 g of dif-
ferent hypromellose strengths (% w/w) were poured into a paper cup and left 
for 2 or 10 min. A one-way ANOVA was performed to compare volume loss 
percentage at 2 and 10 min between different concentrations and between 
buffered and non-buffered solutions. The symbol * indicates difference from 
0.25% solution (**P < 0.01, ***P < 0.001) and # indicates difference from the 
equivalent non-buffered solution (#P < 0.05) at the same time point. All data 
are reported as mean ± SD (n = 3).
weighing the filled syringe (Figure 4a) and this measurement method 
has been used hereafter. Accuracy was also evaluated and no differ-
ence was found between the different doses measured (Figure 4b). 
All doses measured were lower than the target dose. All syringes pre-
sented a residual volume as expected, with the 5 ml syringe having 
the smallest residual volume (Figure 4c). Measurement error bias 
was tested and no significant difference was observed (P > 0.05, 
Figure 4d). The maximum amount of doses was extracted from a 
stock bottle using a different set of dose combinations as outlined 
in Table 1 (Figure 5). In all cases but one, the volume withdrawn in 
the consecutive doses was lower than the overall expected volume, 
indicating that under-dosing can be a common problem. The smaller 
the volume of the doses withdrawn or the higher the proportion of 
low doses, the lower is the residual volume in the bottle (Figure 5). 
This suggests that fewer extractions of a higher volume lead to an 
excess of residual volume compared with a higher number of small 
doses. No wastage was associated with the dosing.
Simulated stock checks
Different stock check techniques were used to evaluate the volume 
loss associated with each of them. No statistical difference was iden-
tified; on average, all stock checks caused the loss of 2.5 ± 1.3 ml of 
solution (Figure 6).
Discussion
This study provides an insight into ways to improve current prac-
tice in the administration and record-keeping of oral CDs liquid 
formulations. We demonstrated that dosing of these formulations 
with enteral syringes using a suitable bottle adaptor constitutes 
best practice and that local policy should dictate to keep stock 
checks to a minimum that allows to satisfy legal requirements. The 
study did not provide evidence to support a defined percentage 
discrepancy that should trigger further investigation. One of the 
limitations of the study was that a simulated drug solution was 
used and only oxycodone solution was simulated; more studies 
using the commercial formula and a variety of CD formulas would 
be beneficial. Furthermore, only one or two researchers, depending 
on the test performed, undertook the measurements, while in prac-
tice, multiple users could be withdrawing doses from the same 
bottle with a high probability of difference in dosing occurring. 
Therefore, there may still be some risk of bias in the data; how-
ever, it was not feasible for more individuals to undertake the 
experiment.
The storage, use and disposal of CDs in hospitals are governed by 
a combination of legal requirements and local policy. If unexplained 
or unacceptable discrepancies between recorded and actual volumes 
of CDs occur, this can trigger time-consuming investigations. There 
are no clear standards on the amount of acceptable loss during 
normal use of the product in a hospital setting. Overage included 
in manufacturer-supplied bottles and loss during each administra-
tion or balance check may contribute to discrepancies and overall 
loss. To determine actual losses rather than an arbitrary ‘standard’, 
a solution of hypromellose in citrate buffer with similar viscosity 
to oxycodone commercial solutions was formulated. We experimen-
tally identified a concentration of 0.4375% w/w hypromellose in 
citrate buffer as the best formula to achieve the desired viscosity of 
15 mPa·s. We demonstrated that the cup technique is associated, as 
expected, with high volume loss, using both paper and plastic cups, 
and that the percentage loss is dependent on the viscosity and the 
volume of the solution poured into the cup. Since the volume poured 
in the cup is generally not measured, this would lead to a very high 
and variable loss of liquid at every dose administered. Furthermore, 
the dependence on viscosity suggests that different results would be 
obtained if formulations of other CDs were used. Considering that 
the use of this open system is not in line with good infection control 
practice and results in residue being incorrectly discarded, we recom-
mend this method be avoided.
Previous studies[8, 9] indicated that enteral syringes, when correctly 
used, provide the best dose accuracy, and for this reason, all subsequent 
experiments were performed using an enteral syringe and withdrawal 
of the solution via a rubber bung permanently fitted to the stock bottle. 
Our study showed that the use of the enteral syringes led to under-
dosing, however, all measurements of volume contained in the syringe 
were within a 10% error, considered the maximum acceptable error.[10] 
The observed under-dosing is consistent with previous studies.[11] 
Measurement accuracy, with different volume doses, was also evalu-
ated; accuracy was higher for larger volumes, but there was no statis-
tical difference when comparing volumes in the range of 2.5–10 ml. We 
further evaluated the dead volume of the syringes used; this would not 
contribute to discrepancies but would contribute to the under-dosing 
observed. The difference in dead volume was observed to be correlated 
with the brand of enteral syringe used and the size of the syringe/dose 
measured. When using the same brand syringe a higher dead volume 
was observed for the smaller syringe. It is important to stress that the 
most appropriate size syringe should always be chosen according to the 
volume to be measured.[11, 12] Finally, we evaluated the possible effect of 
measurement error bias by involving a second researcher; the latter was 
not provided with instructions on how to perform the measurements. 
Results showed no statistical difference between the measurements of 
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have little effect on possible volume loss. With the established method-
ology, we investigated if withdrawing a serial number of identical or 
varied doses would lead to a volume loss. Contrary to the findings of 
other researchers,[6] we always observed a residual volume in the bottle 
regardless of the dose-volume or combination of dose volumes with-
drawn from the bottle. The residual volume was dependent on the type 
of doses taken from the stock bottle. These data confirm the observed 
under-dosing discussed above and suggest that discrepancies are very 
unlikely linked to the dosing when an enteral syringe is used with the 
correctly fitting rubber bung. This therefore implies that the regular 
stock checks are linked to discrepancies in residual volumes. Simulated 
stock checks were performed using different techniques as reportedly 
used in different hospital wards. The two measuring devices most com-
monly used on hospital wards for stock checks are 250 ml cylinders 
and 60 ml enteral syringes. In both cases, the liquid must be transferred 
into the measuring device and back into the stock bottle. Fewer ma-
nipulation steps were expected to help eliminate contamination and 
potential volume loss when handling oral solutions. Pouring the solu-
tion into the cylinder was the procedure with the least manipulations, 
however, if the stock bottle is fitted with a permanent rubber bung this 
procedure would not be possible. Limitations in the use of the syringe 
have been identified. Firstly, in case of a volume higher than 60 ml 
more than one syringe must be used. Furthermore, the rubber bung 
that snugly fits the smaller syringes, used for dosing, is unlikely to fit 
correctly the 60 ml syringe. This can lead to spilling and introduction 
of air bubbles that can affect the measurements. In addition, equalising 
the pressure during this process could lead to spillage. Pouring into a 
syringe barrel also provided the possibility of errors as the scale would 
have to be read upside-down. Decanting the solution into a plastic cup 
or glass beaker could help with correct filling of the measuring syringe 
Figure 4 (a) Precision of syringe dose measuring methods using 5 ml of hypromellose 0.4375% (w/w) solution. One-way ANOVA (P < 0.001): Tukey multicomparison 
test *P < 0.05, ***P < 0.001. (b) Volume-dependent accuracy of dose measurement. One-way ANOVA, P > 0.05. (c) Syringe dead volume after each administration. 
One-way ANOVA, P < 0.0001: Tukey multicomparison test ***P < 0.001, ****P < 0.0001. (d) Volume of hypromellose 0.4375% w/w was measured by two different 
experiments with a 10 ml syringe. Data are represented as median (line within the box), 25th percentile (bottom of the box), 75th percentile (top of the box), 10th 
percentile (lower whisker), 90th percentile (upper whisker) plus outliers (n = 100 for 2.5 ml, n = 50 for 5 ml, n = 25 for 10 ml).
Figure 5 Percentage volume left in the stock bottle after extracting all doses 
as described in Table 1. Data are reported as mean ± SD (n = 3). A one-way 
ANOVA P  <  0.0001; Tukey multicomparison test *P  <  0.05, **P  <  0.01 and 
****P < 0.0001.
Figure 6 Liquid loss caused by different methods of taking a stock level. Data 
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but would add steps to the manipulation. In the absence of an ideal 
method, all methods were evaluated to quantify the volume loss they 
were associated with. Overall, each balance-taking method showed less 
than 5 ml loss in volume. It should be also considered that discrepan-
cies are more likely to arise in wards with less frequent/smaller dosing 
because a higher number of stock checks must be performed before the 
stock is completely used.
Conclusion
This paper identifies poor procedures that hospital ward staff should 
avoid in the dosing and administration of liquid oral CDs and best 
practice in dosing and stock checks of CDs is suggested to reduce 
discrepancies. Data demonstrated that dosing with enteral syringes 
was not associated with loss of volume from the stock bottle and it 
should be suggested as the best method for measuring and adminis-
tering doses of liquid CD formulations. The evaluation of different 
methods to perform stock checks failed to identify a method without 
drawbacks. It is therefore suggested that local policy set stock checks 
to a minimum that allows to comply with the current law. This study 
provides healthcare staff with a greater understanding of the likely 
nature of possible losses based on the number of doses or volume 
checks that have been undertaken.
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